1.	Phase III Randomized Study of Cyproheptadine Hydrochloride in Preventing Cancer- or Treatment-Related Weight Loss in Pediatric Patients Receiving Moderately to Highly Emetic Chemotherapy Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 2 to 21 Sponsor: NCI Protocol IDs: SCUSF-0703, MCC-0703, SCUSF 0703, NCT01132547
2.	Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 1) Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: HT-ANAM-301, NCT01387269
3.	Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 2) Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: HT-ANAM-302, NCT01387282
4.	Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study (ROMANA 3) Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: HT-ANAM-303, NCT01395914
5.	A Study Using MABp1 To Increase Overall Survival In Patients With Colorectal Cancer And Weight Loss Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 2012-PT023, NCT01767857
6.	Clinical Study of BYM338 for the Treatment of Unintentional Weight Loss in Patients With Cancer of the Lung or the Pancreas Phase: Phase II Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CBYM338X2202, NCT01433263
7.	Megestrol Acetate With or Without Mirtazapine in Treating Cancer Patients With Weight Loss or Loss of Appetite Phase: Phase II Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 201202023, NCT01501396
8.	The Role of Ghrelin in Cancer Cachexia Phase: Phase II Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CLIN-013-08F, HT-ANAM-208, NCT01505764
9.	Pilot Clinical Trial of Repeated Doses of Macimorelin to Assess Safety and Efficacy in Patients With Cancer Cachexia Phase: Phase II Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: H-27747, NCT01614990
10.	Testosterone for Treating Cachexia in Patients With Advanced or Recurrent Cervical Cancer Phase: Phase I Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 to 59 Sponsor: NCI, Other Protocol IDs: 06-073, R01CA127971, CDR0000629579, GCRC#724, UTMB-06073, IRB#06-073, NCT00878995
11.	Bovine Lactoferrin in Reducing Taste Disturbances in Patients With Colorectal Cancer Receiving Oxaliplatin-Based Chemotherapy Phase: No phase specified Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CCCWFU 98112, NCI-2012-00279, NCT01596634